Sjogren’s Syndrome
Have You Been Diagnosed with Sjogren’s Syndrome
Greater Chicago Specialty Physicians (GCSP) is now enrolling for a new Sjogren’s study at clinic locations in Schaumburg and Orland Park.
The purpose of the study is to demonstrate clinical efficacy, safety and tolerability of Ianalumab 300mg administered monthly or every 3 months compared to placebo in patients with active Sjogren’s syndrome.
You may qualify to participate in a Sjogren’s study if:
- You are 18 years or older
- Have had a diagnosis of Sjogren’s for 7.5 years or less
All study-related care and medications are at cost.
Compensation of $63 is provided for each completed visit.
After completion of the study, you may enter a 2 year extension study with study medication guaranteed.
To find out more please fill out the form below or call (630) 339-5300 ext 510.